In summary, we find that mGluR5 antagonism represents an effective approach to slow and potentially reverse AD progression both at the receptor level, by reducing mGluR5 membrane trafficking, and at the signaling level, by activating autophagy. This evidence concerns the gene GRM5 and Alzheimer disease.